Guinea Pig Complement (lyophilized) with DILUENT
no-image-default.jpg
Datasheet is currently unavailable. Try again or CONTACT US
Datasheet

Guinea Pig Complement (lyophilized) with DILUENT

C200-0005
5 mL
Other, Purification
Have a Question? Ask a Specialist
$181.00 /Per Item
Availability: Ships in approximately 14 days
Shipping info:

$50.00 to US & Canada for most products. Final costs are calculated at checkout.

Description

Background

Special processing techniques are used to yield products with high complement activity and low background cytotoxicity. Guinea Pig Complement is suitable for CFT and SRH.

Application Note

pH: normal Immunoelectrophoresis: normal Hemoglobin: normal IgG Concentration: normal

Storage Condition

Store Guinea Pig Complement at 4° C prior to restoration.  Aliquot contents and freeze at -70° C or below.  Avoid cycles of freezing and thawing.  Centrifuge product if not completely clear after standing at room temperature.  COMPLEMENT IS A TEMPERATURE SENSITIVE PRODUCT.  IMPROPER STORAGE WILL INACTIVATE COMPLEMENT ACTIVITY.

GUINEA PIG COMPLEMENT (lyophilized) with DILUENT - C200-0005
Complement system, tissue macrophages, blood monocytes, protease C3-convertase, mannose-binding lectin pathway, C3, C3a, C3b, C5a, C5b, C6, C7, C8, and polymeric C9, cascade cleavage and activation events, recruit inflammatory cells, anaphylatoxin
Other, Purification
Guinea Pig
Complement
Mixed
Guinea Pig - Mixed
Non-sterile
Lyophilized
Ambient
Expiration date is one (1) year from date of opening.
76mg/ml by Refractometry
None
None
None
Restore with deionized water (or equivalent)
5.0 mL
Albert JR et al. Maternal DNMT3A-dependent de novo methylation of the paternal genome inhibits gene expression in the early embryo. Nat Commun. (2020)
Applications
Other
Timiryasova TM, Luo P, Zheng L, et al. Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus. J Immunol Methods. (2019)
Applications
E, EIA
Gilchuk I, Gilchuk P, Sapparapu G, et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. (2016)
Applications
NEU
Varada JC, Teferedegne B, Crim RL, et al. A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment. Virol J. (2013)
Applications
NEU

Invalid lot number

If you need help finding your CofA, contact us

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.